Influence of exogenous and endogenous factors on the course of psoriasis;Wpływ czynników endo- i egzogennych na przebieg łuszczycy

Polski Merkuriusz Lekarski

Volumn 38, Issue 225, 2015, Pages 169-173

  Trojacka, E ^a   Zaleska, M ^a   Galus, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

environment; genetic factors; psoriasis

Indexed keywords

CALORIC RESTRICTION; CHRONIC DISEASE; COMPLICATION; DISEASE COURSE; FEEDING BEHAVIOR; HUMAN; IMMUNOTHERAPY; MENTAL STRESS; PREVENTION AND CONTROL; PSORIASIS; RISK REDUCTION;

CALORIC RESTRICTION; CHRONIC DISEASE; DISEASE PROGRESSION; FOOD HABITS; HUMANS; IMMUNOTHERAPY; PSORIASIS; RISK REDUCTION BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 84931039598     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ahdout J, Kotlerman J, Elashoff D, et al.: Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis. Clin Exp Dermatol, 2012; 37 (5): 477-483.
2. Andersen PS, Larsen LA, Fowler VG Jr, et al.: Risk factors for Staphylococcus aureus nasal colonization in Danish middle-aged and elderly twins. Eur J Clin Microbiol Infect Dis, 2013; 32: 1321-1326.
3. Armstrong AW, Harskamp CT, Armstrong EJ: The association between psoriasis and obesity: a systemic review and meta-analysis of observational studies Nutr Diabetes 2012 2 e54 pl
4. Baker KA, MacDonald D, Rahman P, et al.: Effective Psoriasis Care Goes Beyond the Skin: A review of psoriatic comorbidities. Advan Psoriasis, 2010; 2: 46-51. ess.co
5. Balbas GM, Regana MS, Millet PU: Study on the use of omega 3-fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol 2011; 4: 73-77 @medp
6. Basavaraj KH, Ashok NM, Rashmi R, et al.: The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol, 2010; 49 (12): 1351-1361. edpress
7. Basavaraj KH, Nawya MA, Rashmi R: Stress and quality of life in psoriasis: an update. Int J Dermatol, 2011; 50: 783-792.
8. Chiasi M, Noun M, Abbasi A, et al.: Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol, 2011; 56 (5): 533-536.
9. Cohen AD, Bonnen DY, Reuveni H, et al.: Drug exposure and psoriasis vulgaris: case-control and case-crossover studies. Acta Derm Venerol, 2005; 85: 299-303.
10. Dika E, Varotti C, Bardazzi F, et al.: Drug- induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol, 2006; 25 (1): 1-11.
11. Fry L, Baker BS: Triggering psoriasis: the role of infections and medications. Clin Dermatol, 2007; 25 (6): 606-615.
12. Gelfand JM, Abuabara K: Diet and weight-loss as a treatment for psoriasis. Arch Dermatol, 2010; 146 (5): 544-546.
13. Grozdev I, Kast D, Cao L, et al.: Physical and mental impact of psoriasis severity as measured by the compact Short Form-12 Health Survey (SF-12) quality of life tool. J Invest Dermatol, 2012; 132 (4): 1111-1116.
14. Higgins E: Alcohol, smoking and psoriasis. Clin Exp Dermatol, 2000; 25: 107-110.
15. Jabłońska S, Majewski S: Łuszczyca i Dermatozy Łuszczycopodobne – w – Dubrowska H, Warowny M, Piotrowski J. (red.): Choroby skóry i choroby przenoszone drogą płciową. Wydawnictwo Lekarskie PZWL, Warszawa, 2010; 205-224.
16. Johnson-Huang LM, Lowes MA, Krueger JG: Putting together the psoriasis puzzle: an update on developing targeted therapies. Dis Model Mech, 2012; 5 (4): 423-433.
17. Koebnick C, Black MH, Smith N, et al.: The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr, 2011; 159 (4): 577-583.
18. Malhotra SK, Mehta V: Role of stressful life events in induction or exacerbation of psoriasis and chronic urticarial. Indian J Dermatol Venerol Leprol, 2008; 74: 594-599.
19. Mrowietz U, Elder JT, Barker J: The importance of disease associations and concomitant therapy for the long-term management of psoriasis patient. Arch Dermatol, 2006; 298: 309-319.
20. Nestle FO, Kaplan DH, Barker J: Psoriasis. N Engl J Med, 2009; 361: 496-509.
21. Prizment AE, Alonso A, Folsom AR, et al.: Association between psoriasis and incident cancer: the Iowa`s Women`s Health Study. Cancer Causes Control, 2011; 22 (7): 1003-1010.
22. Quereshi A, Choi HK, Setty AR, et al.: Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol, 2009; 145 (4): 379-382.
23. Quershi AA, Dominquez PL, Choi HK, et al.: Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol, 2010; 146 (12): 1364-1369.
24. Robertson ED, Bowcock AM: Psoriasis genetics: breaking the barrier. Trends Genet, 2010; 26 (9): 415-423.
25. Sharma A, Dogra S: Management of psoriatic arthritis. Indian J Dermatol Venereol Leprol, 2010; 76: 645-651.
26. Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, et al.: The role of the palatine tonsils in the pathogenesis and treatment of psoriasis. Br J Dermatol, 2013; 168 (2): 237-242.
27. Tan Pei Lin L, Kwek SK: Onset of psoriasis during therapy with fluoxetine. Gen Hosp Psychiatry, 2010; 32 (4): 446.e9-446.
28. Tidman MJ: Improving outcomes in patients with psoriasis. Practitioner, 2013; 257 (1757): 27-30.
29. Warren RB: Psoriasis comorbidities: a worldwide problem? Br J Dermatol, 2011; 165: 929-933.
30. Wolters M: Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol, 2005; 153 (4): 706-714.
31. Wu W, Debbaneh M, Moslehi H, et al.: Tonsillectomy as a treatment for psoriasis. J Dermatolog Treat, 2014; 25 (6): 482-486.
32. Zindanci I, Albayrak O, Kavala M, et al.: Prevalence of metabolic syndrome in patients with psoriasis. Sci World J, 2012;2012:312463.